These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7215006)

  • 1. Cefamandole in the treatment of purulent respiratory infections. Studies of 3 and 4 g daily in 121 patients.
    Pines A; Jabbar MA; Khorasani MH; Raafat H; Sharma JC
    Chemotherapy; 1981; 27(1):68-72. PubMed ID: 7215006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Double-blind comparison of cefamandole and cefazolin in the therapy of respiratory tract infections (author's transl)].
    Jpn J Antibiot; 1980 Mar; 33(3):375-409. PubMed ID: 6995640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial of ceftizoxime and cefamandole in the treatment of serious lower respiratory tract infections.
    Rodriguez J; Vazquez GJ; Bermudez RH; Luina A; Ronda CH
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():209-13. PubMed ID: 6296008
    [No Abstract]   [Full Text] [Related]  

  • 4. Cefoperazone versus cefamandole in the treatment of acute bacterial lower respiratory tract infections.
    File TM; Tan JS; Gardner WG; Baird I
    J Antimicrob Chemother; 1983 Jan; 11(1):75-82. PubMed ID: 6219089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of cefamandole: a new cephalosporin.
    Little PJ; Peddie BA; Pearson S
    Med J Aust; 1979 Feb; 1(3):97-9. PubMed ID: 431451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefamandole in the treatment of lower respiratory tract infections.
    Clarke CW; Hannant CA; May CS; Rawal BD
    J Antimicrob Chemother; 1980 Nov; 6(6):723-31. PubMed ID: 7440465
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience with cefamandole in bacterial infections of children (author's transl)].
    Ichioka T; Miyao M
    Jpn J Antibiot; 1979 Sep; 32(9):901-4. PubMed ID: 501918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.
    Perkins RL; Fass RJ; Warner JF; Prior RB; File TM; Tight RR; Gardner WG; Ruiz DE; Slama TG
    J Infect Dis; 1978 May; 137 Suppl():S110-S118. PubMed ID: 418126
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of cefamandole nafate.
    Rosett W; Hodges GR; Harms J; Gerjarusak P; Dworzack D; Hinthorn DR; Liu C
    Am J Med Sci; 1977; 274(2):153-61. PubMed ID: 341707
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of cefotiam and cefamandole in respiratory tract infections.
    Beumer HM; Olislagers WP; Kahn M; van Hamersveld JD
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):105-8. PubMed ID: 3886564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical studies of cefamandole in children (author's transl)].
    Shinozaki T; Sawai M; Fujii R
    Jpn J Antibiot; 1979 Oct; 32(10):1036-43. PubMed ID: 513285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefamandole nafate: an evaluation of antibacterial activity, serum levels, clinical effect, and incidence of side reactions in 58 patients.
    Ekwall E; Holmgren EB; Lundbergh P; Svanbom M; Tunevall G
    Scand J Infect Dis; 1979; 11(2):135-9. PubMed ID: 462128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial comparing the safety and efficacy of cefonicid and cefamandole in the treatment of patients with respiratory tract infections caused by susceptible pathogens.
    Azanza JR; Honorato J; Rubio A; Cuena R
    Chemioterapia; 1987 Jun; 6(2 Suppl):449-51. PubMed ID: 3334597
    [No Abstract]   [Full Text] [Related]  

  • 14. Cefamandole in the treatment of infections due to Enterobacter and indole-positive Proteus.
    Levine LR; McCain E
    J Infect Dis; 1978 May; 137 Suppl():S125-S132. PubMed ID: 649997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laboratory and clinical studies on cefamandole in pediatric field (author's transl)].
    Hori M; Kohno S; Hashimoto F; Matsunaga T; Kurosu Y; Toyonaga Y; Takahashi T
    Jpn J Antibiot; 1979 Nov; 32(11):1091-100. PubMed ID: 513291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics and clinical studies of a new cephalosporin: cefamandole nafate].
    Di Nola F; Eandi M; Capra E; Soranzo ML; Bosio G; Bramato C; Salassa B; Andrini L; Robecchi GA
    Minerva Med; 1980 May; 71(21):1515-24. PubMed ID: 7383410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbenicillin plus cefamandole in the treatment of infections in patients with cancer.
    Bodey GP; Ketchel S; Rodriguez V
    J Infect Dis; 1978 May; 137 Suppl():S139-S143. PubMed ID: 649998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pediatric experiences with cefamandole nafate].
    Perinotto G; Belloni CL; Robecchi GA; Fiorella G
    Clin Ter; 1981 Apr; 97(2):165-74. PubMed ID: 7237956
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicentered clinical evaluation of cefoperazone for the treatment of lower respiratory tract infections.
    Gardner WG
    Rev Infect Dis; 1983; 5 Suppl 1():S137-44. PubMed ID: 6221383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefamandole in the treatment of soft tissue infections.
    Ramírez-Ronda CH; Quiñones-Soto R; Lugo-Velázquez A; Bermúdez RH
    Chemotherapy; 1982; 28(3):224-8. PubMed ID: 7094663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.